A method of treating bulimia nervosa and related eating disorders by administration of atypical antipsychotic medications
CA 2366838 A1 · Owner: Guadagno, Gina · Inventors: Star, Jodi E.; Guadagno, Gina
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to a method of treating non-psychotic disorders by administration of atypical antipsychotic medications in particular, risperidone. More specifically the invention relates to a method of treating the eating disorder Bulimia Nervosa and Bulimia-related eating disorders by , administration of antipsychotic medications from the group of compounds designated as atypical antipsychotic mediations. Typical dosage amounts may range from 0.1 milligrams to 4 milligrams per day and may be administered in any dosage forms known in the art, including but not limited to oral, intramuscular rectal, transdermal, sustained release forms controlled , release forms, delayed release …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 17, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 17, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 17, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.